We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biochemical Changes in Stored Donor Units Analyzed

By LabMedica International staff writers
Posted on 12 Jul 2018
Print article
Image: The HumaStar 80 clinical chemistry analyzer (Photo courtesy of Human Diagnostics).
Image: The HumaStar 80 clinical chemistry analyzer (Photo courtesy of Human Diagnostics).
Blood transfusion with allogeneic blood products is a common medical intervention to treat anemia or prepare patients for surgical procedures and generally, the blood units are secured and stored prior to expected transfusion.

During storage, several physical and biochemical changes take place in blood products that await transfusion, and the most affected product is whole blood. These changes known collectively as red cell storage lesion are progressive events that affect blood products stored for longer period than products stored for a short period.

Medical Laboratory Scientists at Mbarara University of Science and Technology (Mbarara, Uganda) recruited consecutively a total of 200 blood recipients were categorized into two study arms: group I of 100 received fresh blood and 100 in group II received old blood. A total of 2 mL of venous blood was collected from each participant in EDTA tubes before transfusion for pre-transfusion hemoglobin (Hb) estimation and after transfusion for post-transfusion Hb estimation. Each cross-matched unit was sampled to collect plasma for pH, lactate and potassium assays.

The Hb level was estimated using a Beckman Coulter Diagnostics full hemogram machine; donor lactate level was determined using HumaStar 80; and the potassium and pH in the donor units were determined by Human Diagnostics’ HumaLyte assays. Donor units were cultured in blood agar medium and incubated for 24 hours at 37 °C.

The team reported that the pH of the stored blood dropped from 7.4 to 7.2 in the first three days to ~7.0 by day 11 and to <7.0 by day 35. The mean rise in lactate level was 25 g/dL in blood stored for 0 to 11 days and 32.4 g/dL in blood stored for 21 to 35 days. The highest increase was encountered in blood stored beyond 28 days: 40–57 g/dL by 35 days. Potassium levels equally increased from ~4.6 mmol/L in the first five days of storage to ~14.3 mmol/L by 11 days. From the third week of blood storage and beyond, there was exponential increase in potassium levels, with the highest record in blood units stored from 30 to 35 days.

The authors concluded that whole blood stored for more than 14 days has reduced efficacy with increased markers of red cell storage lesion such as increased potassium level, lactate and fall in pH and these lesions increase the length of hospital stay. The study was published on June 25, 2018, in the Journal of Blood Medicine.

Related Links:
Mbarara University of Science and Technology

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
New
Tabletop Centrifuge
Mikro 185

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.